LSI’s Post

[MEET THE JURY 4] Get ready to meet our jury! We're excited to introduce the experienced investors who will be assessing the pitches of 20 EIC Fund companies on 13 November at the 𝗘𝗜𝗖 𝗮𝗻𝗱 𝗝&𝗝 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗗𝗮𝘆, 𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗯𝘆 EuroQuity - Bpifrance.   ⭐ Stavriana A. Kofteros Founder, Partner at W11 Ventures. W11 Ventures is a boutique growth and innovation advisory and venture friend that scales startups, connects corporates with the innovation ecosystem, and fosters long-term partnerships for successful innovative businesses. With a proactive role in value creation and growth, W11 is a trusted strategic partner to scale companies in various sectors, particularly ICT and life sciences/health. Its unique 360 approach and expertise create competitive advantages and add value by interconnecting ecosystems and filling gaps.   ⭐ Jia-Yi H., Partner at Cathay Health. Cathay Health is the healthcare VC arm of Cathay Health. We invest in venture and growth stage companies operating at the convergence of health, life science and tech to address large unmet medical needs.   ⭐ Ingrid Kelly Spillmann, Partner at xista science ventures. xista science ventures is an Austria-based investor in early stage academic deeptech and life science spinoffs and startups. ⭐ Linus Rieder serves as Principal at 415 Capital. 415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 25 years, the team has been providing exceptional entrepreneurs with capital, expertise, and market access. Want to be part of it? Make sure to reserve your spot. #HealthTech #biotech #medtech #eicAccelerator #EUeic #Healthcare #Investors

Effective collaboration between financial investors and strategics plays an important role in the fundraising ecosystem. How do investors and strategics approach these partnerships to achieve the best outcomes? In our upcoming #LSIEurope24 panel, "How do Financial Investors and Strategics Partner to Support Venture-Backed Startups?", we’ll hear from both financial investors and strategics as they explore the dynamics of these collaborations. Our panelists will share their stories and expertise on forming successful partnerships, navigating challenges, aligning goals, and driving innovation. Featured Panelists: • Nate Harrington (Moderator), Managing Partner, Philips Ventures • Carissa Bellardine Black, Senior Director, Venture Capital, Medtronic • Auriel August, MD, Principal, SANTÉ Ventures • Janke Dittmer, General Partner, Head of European HealthTech Investments, Gilde Healthcare • Alexander Schmitz, Partner, Endeavour Vision Join us at LSI Europe ‘24 this September 16-20th to see more panel sessions like this and connect with nearly 1,000 global Medtech and Healthtech leaders in Sintra, Portugal.

Attention of partners, managers, investment directors and private investors investing in Healthtech. Usually they ask you for money and participation in demo day. From me personally and the 4PM Ventures team for you another offer: 1. Please read our post below and express your opinion - do you agree with these theses or not. 2. Ask clarifying questions if they appear. 3. Add to friends if we do not know each other yet. 4. Send our offer to take part in the laboratory to your portfolio companies - the start of the program - a new format for supporting startups, supported by EIT Health, on June 12th. 5. Request an invitation to open a laboratory and a foresight about the future of healthcare, which will take place within the laboratory. More information about the laboratory on the 4PM Ventures page, link to registration in the first comment Dear colleagues, please note this offer: Nathan Kharchenko, Valentin Doronichev; Anna Gishko; Allan Gobbs; Yuri Mashintsev; Jacopo Mele; Marija Varadinova; Yury Kukushkin; Khaled Arwani; Kirill Vesselov; Nikolai Denisov Commercialization Reactor; Zaz Ventures Change Ventures LongeVC; Coöperatie VGZ #4pm; #vc; #health; #healthtech; #medicine

Next week, the Cedars-Sinai Technology Ventures and Accelerator teams will host 11 Singapore startups for a week of specialized curriculum around the current healthcare landscape in the US and internationally. Together with Coronet Ventures and Enterprise Singapore, this Singapore Innovation Week will explore crucial topics such as regulatory requirements, the role of internal review boards, and legal considerations for international companies. Check out the participating Singapore companies: BluMaiden Biosciences Carecam HiCura Medical Pte Ltd Kinexcs KroniKare Pte Ltd KYAN Technologies NalaGenetics Nousq Pte Ltd PedraTech Qritive TIIM Healthcare Read the official Cedars-Sinai press release here: https://lnkd.in/gG5MY36U We at the Accelerator cannot wait to host these amazing companies and see how their innovations are changing the healthcare landscape! #CSaccelerator #GlobalAlliances #healthinnovate #healthaccelerator #HIT #healthdisruptors #CSAclass10

🚀 A Conversation on Enabling Healthcare Innovation with Venture Capital: I recently had the privilege to welcome Nicole Graner from the Süddeutsche Zeitung at our YZR Capital headquarters. Article in 1st comment. Tldr: 🔎 Critical need for venture capital in fostering healthcare innovation. 🔎 How our expertise-driven approach is making a difference. 🔎 My journey as a physician, entrepreneur and investor, always deeply intertwined with my passion for #healthtech. 💡 That's why: alongside Markus Feuerecker I co-founded YZR Capital with a clear vision: to propel European healthtech startups into global leadership positions. 💡 We strongly believe that our team’s expertise in health is key to supporting founders who are dedicated to change the European healthtech ecosystem. ✔ Apparently our name is difficult to pronounce – for everyone who is still wondering, it’s “wise” with an R at the end ;) -> Thanks again to Nicole - it was a pleasure! And thanks to the fantastic team at YZR Capital - Christina Schmidt, Paul Epple, Urs Keller, Holger Ebersberger, Elmar Willebrand, Michael Dr. Bitzer. #HealthTech #VentureCapital #Innovation

📣 Attention European investors and start-up support organisations! Your input is needed to shape a sustainable future for early-stage investments in Europe. 🇪🇺 🌍 MEDVIA is a partner in the Healthy Investment Central Eastern Europe (#HICEE) program, which aims to revolutionise the #healthtech #investment landscape by supporting early-stage start-ups, fostering cross-border collaborations and boosting #investments. 😀 Sounds good, right? So give us a bit of a hand in understanding the challenges, needs and best practices in early-stage investment in this region by filling out our survey! 👉🏾 https://lnkd.in/d8njKg93   👐 Whether you're an #investor or a start-up support organisation, your role in fostering the growth and success of start-ups is invaluable. 📨 Feel free to also pass this survey along to other investors, incubators, accelerators and any other start-up support organisations you know!   #InvestmentGap #CentralEasternEurope #startups #investors Our partners in HICEE: Civitta, COBIN Angels, Crowdberry, EIT Health InnoStars, EIT Health Belgium-Netherlands Hungarian Business Angel Network, Ljubljanski univerzitetni inkubator (LUI), Delft University of Technology, EIT Health

Always keen to share real corporate x startup collaborations that accelerate innovation. Here's the story of Alistair (Axiom)and Patrick (Roche) on their fine collaboration and co-creation of a procurement catalogue solution. 🤝 Collaboration, this wasn’t just about working together—it was about truly co-creating a solution. Both sides were vested and deeply involved, adapting and pivoting as challenges arose and feedback came in.  🎯 User first, the team put a big emphasis on making sure the solution really worked for the users. The goal was to create something that wasn’t just functional, but also a joy to use 😁   🌎 Bold Moves and taking risk, both Axiom and Roche took some brave steps here; Roche took a chance on a startup, and Axiom put all its energy into developing a solution for a single major client. These risks paid off, meeting and even surpassing expectations, and setting the stage for exciting future growth. The full youtube video link in the comments. Looking forward to meet again soon at DPW Amsterdam 😉 📍 DPW Amsterdam 2024 🇳🇱 📅 October 8-10 https://conference.dpw.ai/ #startups #procurement #dpwamsterdam #innovation

Germany-based Earlybird Venture Capital Health recently successfully concluded the final closing of its second fund. 💸 Final close of its €173m (£147.6m) backed by major European institutional investors including health insurers, strategic investors, and public and private organisations. €20m was committed from British Patient Capital. 💡’Healthcare sectors, with an emphasis on #digitalhealth, diagnostics, medical devices, research and development tools and #biopharma.’ 🌍 The fund is targeting European startups. 📈 ‘This fund is more than twice the size of Earlybird’s first healthcare-focused fund, Health I, which reached €85 million at its final closing.’ 💭 “Innovation in the #UK is second to none and is underpinned by world-class science…we are committed to supporting the European startup ecosystem and fostering the development and growth of some of the world’s most exciting new companies who stand to positively impact the lives of millions of people across the globe in the future.” - John Yianni, partner, Earlybird Health. 🗞️Oscar Hornstein UKTN https://lnkd.in/eCnHfwwN 👏 For the #AudaciousInvestors unleashing innovation and empowering tomorrow🚀 Roland Manger I John Yianni I Rabab Nasrallah, I Junkai Z. I Dr. Marie-Thérèse Buttlar I Thom Rasche I Lionel Carnot I Rainer Christine I Florent Gros I Dr. Christoph Massner I Christine Hockley I Team Earlybird Health … #venturecapital #vc #funds #startups #entrepreneurs #funding #tech #entrepreneurship #technology #innovation #healthtech #europe

🚀 Hear for the CO-AX Community 🚀 "CO-AX has helped us open several doors, everything from quality assurance of the business to capital raising/financing and exposure to relevant partners and customers. Their support has been fantastic, with a clear tailored focus on what has been important for our particular business." Says Peder Remman, CEO Boneprox Our portfolio companies showcases AI-driven, deep tech, and innovative startups that are transforming the way healthcare is delivered. These companies, from pre-seed to growth stages, are addressing global health challenges with cutting-edge solutions. Learn more about the CO-AX companies: https://lnkd.in/dCEaeHiH Learn more about us: https://lnkd.in/e6MGJd_u Join us in our vision of accelerating tech for health. Apply to the program now! https://lnkd.in/e-JujBy6 #COAX #startup #accelerate #healthtech #portfolio

Appreciate the mention, Healthtech VCNews! 👏 Visit our website to learn more about how we help you connect with the right investor from our list of 110,000+ verified investors!